Iterion Therapeutics Makes Significant Progress with Tegavivint in Colorectal Cancer Treatments Iterion Therapeutics has announced the dosing of the first patient in a clinical trial for its innovative treatment Tegavivint against colorectal cancer, marking a critical advancement in cancer therapy.

Iterion Therapeutics Makes Significant Progress with Tegavivint in Colorectal Cancer Treatments #USA #Houston #Iterion_Therapeutics #Tegavivint #Wnt_Inhibitor